
Frequently Asked Questions
The market is segmented based on Global Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) Market, By Product (Design Tools, Plasmids, Vectors, Library, Control Kits, Proteins, Genomic RNA, and Others), Application (Genome Editing/ Genetic Engineering, Genetically Modified Organisms, Agricultural Biotechnology, and Others), End User (Hospitals, Diagnostic Centers, Others)– Industry Trends and Forecast to 2029
.
The Global Clustered Regularly Interspersed Short Palindromic Repeats Crispr Market size was valued at USD 762.39 USD Million in 2021.
The Global Clustered Regularly Interspersed Short Palindromic Repeats Crispr Market is projected to grow at a CAGR of 10.7% during the forecast period of 2022 to 2029.
The major players operating in the market include Applied StemCell AGilant Technologies Inc. , Synthego , Thermo Fisher Scientific Inc , GenScript , Addgene , Merck KGaA , Intellia TherapeuticsInc , Cellectis , Precision Biosciences , Caribou BiosciencesInc , Transposagen BiopharmaceuticalsInc , OriGene TechnologiesInc , Novartis AG , New England Biolabs Ltd. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..